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A novel thermal detection method based on
molecularly imprinted nanoparticles as
recognition elements†
Francesco Canfarotta, *a J. Czulak, a K. Betlem, b A. Sachdeva, c
K. Eersels, d B. van Grinsven, d T. J. Cleijd and M. Peeters *b
Molecularly Imprinted Polymers (MIPs) are synthetic receptors that are able to selectively bind their
target molecule and, for this reason, they are currently employed as recognition elements in sensors. In
this work, MIP nanoparticles (nanoMIPs) are produced by solid-phase synthesis for a range of templates
with diﬀerent sizes, including a small molecule (biotin), two peptides (one derived from the epithelial
growth factor receptor and vancomycin) and a protein (trypsin). NanoMIPs are then dipcoated on the
surface of thermocouples that measure the temperature inside a liquid ﬂow cell. Binding of the template
to the MIP layer on the sensitive area of the thermocouple tip blocks the heat-ﬂow from the sensor to
the liquid, thereby lowering the overall temperature measured by the thermocouple. This is subsequently
correlated to the concentration of the template, enabling measurement of target molecules in the low
nanomolar regime. The signiﬁcant improvement in the limit of detection (a magnitude of three orders
compared to previously used MIP microparticles) can be attributed to their high aﬃnity, enhanced con-
ductivity and increased surface-to-volume ratio. It is the ﬁrst time that these nanosized recognition
elements are used in combination with thermal detection, and it is the ﬁrst report on MIP-based thermal
sensors for determining protein levels. The developed thermal sensors have a high selectivity, fast
measurement time (<5 min), and data analysis is straightforward, which makes it possible to monitor bio-
molecules in real-time. The set of biomolecules discussed in this manuscript show that it is possible to
cover a range of template molecules regardless of their size, demonstrating the general applicability of
the biosensor platform. In addition, with its high commercial potential and biocompatibility of the MIP
receptor layer, this is an important step towards sensing assays for diagnostic applications that can be
used in vivo.
1. Introduction
Molecularly Imprinted Polymers (MIPs) are synthetic receptors
with recognition sites that are complementary to the template
in terms of size, shape, and orientation of functional
groups.1–3 Bulk imprinting, the traditional approach to syn-
thesize MIPs, leads to the formation of microparticles that are
not straightforward to incorporate into sensing devices.4 The
preparation of nanoparticles from a solid-phase support
(hereafter referred to as nanoMIPs) holds great potential both
in the diagnostic and therapeutic sector, also in light of their
good biocompatibility.5,6 Currently, nanoMIPs produced by
solid-phase synthesis are applied as recognition elements in
both optical and electrochemical sensors and assays.7,8 In
addition, they can be considered as replacement for antibodies
and have been used for the detection of several targets in
ELISA-type assays.9–13 The use of synthetic antibodies has a
number of distinct advantages over their natural counterparts,
including their cost-eﬀectiveness, simple and scalable syn-
thesis, and that no animals are required for the production
process.14,15 Due to their robust nature, nanoMIPs can be
employed in harsh chemical environments such as extremes of
pH, temperature and also in organic solvents.16,17 Since
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nanoMIPs are not proteins, they are not susceptible to degra-
dation or proteolysis.12 This makes them re-usable and viable
for use in more remote geographical areas where healthcare
infrastructure is limited. It is also beneficial for the in situ
monitoring of biomolecules, since field sensors may need to
withstand relatively harsh conditions depending on their
designated use.18
Whilst MIPs are extremely suitable for extraction and
quantification of target molecules in complex matrices, their
use in biosensors remains limited. This can be explained by
two factors; first, diﬃculties to incorporate MIPs into sensors
platforms and, second, lack of detection methods that allow
simple interpretation and are suitable for integration into por-
table devices.19,20
In a previous research, we have demonstrated that thermal
detection methods oﬀer an interesting alternative to tra-
ditional biosensor read-out platform (e.g. electrochemical
detection and chromatographic techniques) since it requires
the use of only two thermocouples and a heat-source, and the
device can be used for measurements in real-time.21,22 MIP
microparticles were functionalised on electrode surfaces,
which were subsequently mounted into a patented thermo-
couple device.22,23 The changes in thermal resistance at the
solid–liquid interface24 were then correlated to the bio-
molecule concentration in the sample. In a follow-up on this
research, these MIP microparticles were directly deposited
onto Screen-Printed Electrodes (SPEs) to determine neuro-
transmitter concentrations.25 SPEs are disposable electrodes
with low batch-to-batch inconsistencies, which oﬀer additional
material advantages such as their flexibility and low-cost.26
However, algorithms are required to determine the heat-trans-
fer resistance and the biomolecule concentration is deter-
mined in an indirect way. A straightforward approach is to
directly deposit MIP particles onto thermocouples that are
used for the determination of the temperature in the liquid.27
While this simplifies data analysis, it requires the use of
additional layers to attach the MIP layers on the thermo-
couples. In addition, the microparticles hinders heat-flow
through the thermocouple, thereby rendering detection less
eﬃcient and increasing the noise on the signal. In this manu-
script, we will use nanoMIPs prepared by the solid-phase
approach that can be directly applied onto thermocouples by
means of dipcoating. Such nanoMIPs have been developed for
a variety of targets that diﬀer in size, going from a small mole-
cule (biotin), to peptides (vancomycin and an epitope of the
epidermal growth factor receptor) to a large protein (trypsin).
We will demonstrate that we can measure these molecules at
physiologically relevant concentrations with these thermal
sensors. The developed sensors are a very powerful analytical
tool due to their straightforward preparation process, simpli-
city to operate, rapid and low-cost detection. Molecular
imprinting technology is versatile and the sensor platform can
be extended to other biomolecules by simply varying the
nanoMIPs. In addition, due to the biocompatibility of the
sensors, this is the first step towards an in vivo diagnostic tool
with potential clinical applications.
2. Materials and methods
2.1. Preparation of template-modified glass beads (solid-
phase functionalization)
Glass beads (Spheriglass® 2429 CP00, 53–106 μm diameter,
from Blagden Chemicals, UK) were first activated by boiling in
a 2 M NaOH solution for 15 min, then washed with deionized
water and rinsed with acetone, dried at 80 °C and sub-
sequently incubated overnight in 2% v/v 3-aminopropyltri-
methyloxysilane (APTMS) in a dry toluene solution (0.4 mL
solution per g glass beads). This last step leads to beads
bearing NH2 surface groups.
For the preparation of EGFR-modified solid-phase, 60 g of
glass beads were placed in a solution of succinimidyl iodoace-
tate linker, at 0.2 mg ml−1 in acetonitrile for 2 h in the dark
(0.4 ml solution g per glass beads). The succinic moiety allows
the linker to react with the amine-derivatised solid-phase, and
the haloacetyl group enables subsequent coupling with the
thiol group from cysteine added on the N-terminus of the
peptide sequence (obtained from Ontores Biotechnologies,
China). Afterwards, the beads were washed with 400 ml of
acetonitrile in a sintered glass funnel and placed in a bottle
containing 7 mg of the cysteine-modified peptide epitope in
40 ml of deoxygenated phosphate buﬀered saline (PBS) con-
taining 5 mM EDTA, pH 8.2. After overnight incubation, the
beads were washed with 700 ml of water in a sintered funnel
and used for the synthesis of nanoMIPs.
For the preparation of biotin nanoMIPs, 60 g of APTMS-
derivatised glass beads were incubated with a solution of
biotin (Sigma Aldrich) containing 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide hydrochloride (EDC) and
N-hydroxysuccinimide (NHS) (both from Sigma Aldrich) at 0.5,
10 and 15 mg ml−1 respectively, in PBS pH 7.4. After overnight
incubation, the beads were washed with 500 ml of water in a
sintered funnel and used for the synthesis of nanoMIPs.
For the preparation of trypsin- and vancomycin-modified
solid-phase, APTMS-derivatised glass beads were first incu-
bated in a 7% glutaraldehyde solution in PBS for 2 h.
Afterwards, the beads were washed with 700 ml of distilled
water and placed in a bottle containing either trypsin
(0.1 mg ml−1) or vancomycin (0.2 mg ml−1) in PBS, and incu-
bated overnight at 4 °C. After overnight incubation, the beads
were washed with 500 ml of water in a sintered funnel and
used for the synthesis of nanoMIPs.
2.2. Synthesis of biotin, vancomycin, trypsin and EGFR-
imprinted nanoMIPs
The procedure has been adapted from ref. 5 and 6. The follow-
ing monomers were dissolved in PBS 5 mM, pH 7.4 (100 ml):
N-isopropylacrylamide (39 mg), N,N′-methylenebisacrylamide
(6 mg), N-tert-butylacrylamide (33 mg), N-(3-aminopropyl)
methacrylamide hydrochloride (5.8 mg), acrylic acid (2.2 μl).
N-tert-Butylacrylamide was previously dissolved in ethanol
(1 ml) and then added to the aqueous solution.
The solution containing the monomers was degassed
under vacuum and sonicated for 5 min, and then purged with
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N2 for 20 min. Then, 60 g of template-derivatised glass beads
were added to the solution. Polymerization was initiated by
adding ammonium persulfate aqueous solution (800 μl, 60
mg ml−1) and N,N,N′,N′-tetramethylethylenediamine (24 μl).
The headspace was flushed with N2 and the bottle sealed with a
screw cap. Polymerization was carried-out at room temperature
for 1 h. Subsequently, the content of the polymerization vessel
was poured into a solid-phase extraction cartridge (60 ml)
equipped with a frit (20 µm porosity). A total of 9 washes with
20 ml of distilled water at 20 °C was carried out to remove low
aﬃnity nanoMIPs, oligomers and unreacted monomer.
Afterwards, the SPE cartridge containing the solid-phase was
placed in a water bath at 70 °C for 15 min. An aliquot of 20 ml
of distilled water pre-warmed at 65 °C was poured into the SPE
to collect the high-aﬃnity nanoMIPs. This procedure was
repeated seven times, until about 140 ml of a solution of high-
aﬃnity nanoMIPs in water was collected. To ensure complete
removal of all unreacted monomer from the bulk of the nano-
particles, aliquots of the collected solution were concentrated
down to 2 ml using a centrifugal dialysis cartridge fitted with a
membrane with 30 kDa molecular weight cut-oﬀ (Amicon
Ultra, Merck Millipore) to remove unreacted monomers and
other side products. This was followed by seven washes (14 ml)
with deionized water on the same dialysis cartridge.
2.3. Size and concentration analysis of nanoMIPs
The particle size was measured with a Zetasizer Nano (Nano-S)
particle-size analyser from Malvern Instruments Ltd (UK). An
aliquot of the dispersion of nanoMIPs in distilled water was
sonicated for 2 min and then analysed by DLS at 25 °C in a
3 cm3 disposable polystyrene cuvette. The instrument auto-
matically chose attenuator position, measurement duration
and number of runs. The values are reported as an average of
4 measurements. Transmission Electron Microscopy (TEM)
images of nanoMIPs were taken using a JEOL JEM 1010,
100 kV high contrast TEM equipped with a Gatan SC1000
Orius CCD camera (Gatan, Abingdon Oxon, UK). Samples for
the analysis have been prepared by depositing a drop of the
nanoMIPs dispersion, previously filtered through a 1.2 μm PES
syringe filter, on a carbon-coated TEM copper grid (400 mesh),
and leaving them to dry at room temperature. The nanoMIP
concentration was assessed by freeze-drying an aliquot (20 ml)
of the particle solution and then weighing the solid.
2.4. Thermal measurements of nanoMIPs sensors
Thermocouples of type K from TC Direct (Uxbridge, United
Kingdom) were dipped into a nanoMIP solution for 60 s and
withdrawn at a rate of 5.1 cm min−1. The functionalised ther-
mocouples were subsequently air-dried at room temperature.
The presence of the particles on the tip of the thermocouples
was determined by Scanning Electron Microscopy analysis
with a Supra 40VP Field Emission Scanning Electron
Microscope from Carl Zeiss Ltd (Oberkochen, Germany). The
functionalised thermocouples were then inserted into a heat-
transfer set up with an in-house design, which has been
described in detail in previous work.23,24 This set up is
coupled to a Perspex flow cell, which exposes the receptor layer
to buﬀer and target solutions. A copper block underneath the
sample serves as a heat-sink. Its temperature (T1) is actively
steered with a proportional-integral-derivative (PID) controller
that is attached to a power resistor. In all measurements, the
temperature was kept constant at 37.00 ± 0.02 °C to mimic
in vivo conditions. The functionalised MIP-thermocouple
monitors the temperature in the flow cell, which is defined as
T2 and is sampled every 1.0 s.
In previous work,27 the authors described polylactic acid
(PLLA) coated thermocouples that were impregnated with MIP
particles. The PLLA-sheet (∼2 μm thickness) forms a thermally
insulating layer around the thermocouple over the entire sheet
within the flow cell. In that case, binding of target molecules
to the MIP particles will increase the thermal resistance of the
sheet, leading to a decrease in heat loss over the thermocouple
and an overall increase of the measured temperature.
In this work, only the sensitive area of the tip of the
thermocouple is covered by a very thin layer of nano-sized MIP
particles (Fig. 1). The insulating eﬀect of target rebinding has
little to no eﬀect on the thermocouple heat sink eﬀect but
does decrease the sensitivity of the tip in accurately determin-
ing T2. It was previously demonstrated
21 that the thermal resis-
tance at the solid–liquid interface increases when the analyte
binds to MIP particles functionalised onto planar electrodes.
With this method, the thermal resistance increases between
the thermocouple tip and the liquid inside the flow cell and as
a result, the measured temperature in the flow cell (T2) is
significantly lowered. The benefit of this method is that a
nanosized layer is obtained, which will enhance heat-flow
through the surface and significantly increase eﬀect size. The
principle is demonstrated in Fig. 1, where TCU represents the
temperature control unit of the heat sink (T1) and the tempera-
ture monitored in the flow cell (T2).
Prior to each measurement, the flow cell was filled with a
solution of phosphate buﬀered saline (PBS) and left to stabil-
ize for 45 min. Subsequently, solutions with increasing target
concentration in PBS were added (0, 5, 10, 100, 500, 1000 nM)
using an automatic syringe pump (ProSense, model NE-500,
the Netherlands) at a constant rate of 0.25 mL min−1. The
signal was left to stabilize for 30 min between each addition.
The temperatures T1 and T2 were recorded throughout the
measurement. Dose–response curves were constructed by plot-
ting the target concentration vs. the relative change in thermal
signal. The selectivity of the MIP sensor was determined by
measuring the thermal response with a chemical compound
that is similar to the original target. For these experiments, the
signal was stabilised in PBS for 45 min and PBS solutions of
increasing concentration (50, 100, 500, 1000 nM) of a similar
analyte were added with 30 min intervals. Specificity tests were
carried out with structural analogues or molecules which can
act as interferents in a given matrix. In particular, pepsin was
used in the case of trypsin nanoMIPs, teicoplanin for vanco-
mycin nanoMIPs, ascorbic acid for biotin nanoMIPs and
finally a related peptide sequence Beta-2-Microglobulin
(hereafter referred to as B2MG) for EGFR nanoMIPs.
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For proof-of-application in complex media, measurements
were conducted with saliva samples spiked with EGFR. First,
electrodes were stabilized in PBS for 30 min which was followed
by addition of saliva diluted 1 : 1 with PBS. Subsequently, saliva
samples (all diluted 1 : 1 with PBS to reduce viscosity) were
spiked with 5, 10, 100, 1000 and 10 000 nM EGFR.
3. Discussion
3.1. Production and characterization of nanoMIPs
Herein we assess whether molecularly imprinted nanoparticles
(nanoMIPs) can act as recognition elements once they are
coated onto thermocouples, and whether they can improve the
achievable limit-of-detection (LoD) and specificity of thermal
MIP sensors. The innovative solid-phase approach here
employed in the production of nanoMIPs relies on the covalent
immobilisation of the template molecule on a solid support
(e.g. glass beads, average diameter 75–90 μm). Polymerisation
is then initiated in the presence of this support bearing the
immobilised template. After polymerisation, the solid support
acts as an aﬃnity medium to isolate the high-aﬃnity
nanoMIPs from the remaining monomers, oligomers and low-
aﬃnity polymers (Fig. 2). Because of the aﬃnity purification
step, nanoMIPs possess high aﬃnity and specificity toward
their targets and exhibit a homogeneous distribution of
binding site aﬃnities.5 As previously demonstrated, the advan-
tage of such solid-phase approach is the production of
nanoMIPs virtually free from templates and in a short time-
frame (few hours). Moreover, this approach can be easily auto-
mated to allow the manufacture of nanoMIPs with improved
batch-to-batch consistency.6 Interestingly, nanoMIPs produced
by the solid-phase approach here described have been success-
fully employed as imaging tools in vivo, thus demonstrating
their potential in diagnostics.28
NanoMIPs against biotin, trypsin, vancomycin and an
EGFR epitope were produced, therefore covering a wide range
of template sizes and showing the general applicability of the
method. To date, nanosized MIP structures have not been
used in combination with thermal detection. In addition, this
is the first report on the use of this platform with MIPs for the
detection of large peptides and proteins. The imprinting of
these compounds is notoriously diﬃcult due to sensitive struc-
tural nature of proteins and the need to imprint in an aqueous
environment, limiting the choice of monomers.29 Therefore,
in combination with the biocompatibility of the recognition
layer,5,28 this method holds great potential as a protein sensor
that can be incorporated into e.g. a catheter for in vivo sensing.
The hydrodynamic size of the four diﬀerent nanoMIPs in
water was determined by DLS (Table 1). It should be noted
that the hydrodynamic size can significantly diﬀer from the
dry size by TEM for several reasons: first, the polymer tends to
hydrate and swell when in solution; secondly, nanoMIPs can
undergo a certain level of agglomeration in solution, which
leads to an apparent increase in the size by DLS; thirdly, it is
worth noting that DLS analyses the light scattered from the
sample as a whole. However, smaller particles scatter less light
than larger particles (intensity of the scattering proportional to
Fig. 1 This is a schematic representation and Scanning Electron Microscopy image of the thermocouple that is dipcoated with nanoMIPs on the tip,
located at T2. Heat can freely pass through the thermocouple in the case of buﬀer solution, while when the analyte binds to the MIP-layer it blocks
the heat-ﬂow in a certain direction and decreases the temperature that is measured at T2. The temperature at T1 is strictly controlled at 37.00 °C and
the ﬂowcell into which the thermocouple is placed is made of Perspex.
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the sixth power of the particle diameter), therefore the scat-
tered light of these latter (or even from aggregates) can cover
the signal from smaller particles, and hence the apparent par-
ticle size distribution can be shifted towards larger sizes.
3.2. Thermal experiments with thermocouples
functionalized with nanoMIPs
Subsequently, these nanoMIPs were functionalized onto ther-
mocouples using dipcoating.
In an initial experiment, a blank thermocouple (not coated
with nanoparticles) was exposed to solutions with increasing
concentrations of the EGFR peptide (5, 10, 100, 500, 1000,
10 000 nM). It is clear that there is no significant eﬀect on the
temperature of the blank thermocouple upon stabilization in
PBS compared to PBS with a high concentration (5–10 000 nM)
of EGFR (Appendix A†). Subsequently, thermocouples dip-
coated with nanoMIPs for EGFR were inserted into the set up
and the temperature was monitored when solutions with
increasing concentrations of EGFR (5–1000 nM) were added to
the flow cell. The temperature of T1 was strictly controlled at
37.00 ± 0.02 °C. In the case of T2, decreases in the temperature
were measured after each injection due to the addition of fluid
at room temperature to the set-up. The temperature control
unit increased the power to regulate it back to the original
temperature of T1, which requires a short stabilization time. In
the case of the blank thermocouples where no binding occurs,
T1 goes back to baseline level shortly after injection and T2
returns to this its initial level after a few minutes. When
binding occurs at the MIP layer of the tip of the functionalised
thermocouple, T1 is retained at its set temperature but T2
(which is not controlled but merely monitored) stabilizes at a
value below the baseline (see Fig. 3a). Changes in T2 were
recorded after addition of solutions with EGFR concentrations
of 5 nM or higher, with the linear range of the sensor between
5–500 nM (see Fig. 3b). The thermal signal saturated at a
maximum concentration of 1000 nM when T2 had dropped
from 35.60 ± 0.05 °C to 35.00 ± 0.05 °C. Noise on the thermal
signal was around 0.05 °C (∼0.15%) throughout the experi-
ment. The diﬀerence in temperature was subsequently con-
verted into an eﬀect size by dividing the diﬀerence in tempera-
ture over the initial temperature, leading to a 1.90 ± 0.05%
change in thermal signal at 1000 nM (Fig. 3b). Experiments
performed with a non-related peptide sequence (B2MG)
resulted in a 0.5 ± 0.04% change of the thermal signal at a con-
centration of 1000 nM. A minor response was expected due to
the similarity that this compound bears with the target
peptide EGFR. However, since this was nearly a factor of four
lower compared to the original template (1.9%) at the same
concentration, the experiment demonstrated the high selecti-
vity of the developed biosensor platform.
Standard deviations were calculated by averaging out the
data over 200 data points and are indicated as error bars in
Fig. 3.
The LoD can be determined at the concentration at which
the signal is equal to three times the standard deviation on the
baseline level signal. With the dose–response curve and
obtained fit, a LoD value of 3 ± 1 nM in PBS was estimated,
which was an improvement of nearly three orders of magni-
tude compared to previous works on thermocouples.27 The
explanation behind this is threefold; first, there is a ten-fold
decrease in layer thickness that promotes heat-flow through
the surface and increases the response to changes in the
thermal signal and, second, the increased surface-to-volume
ratio of the nanoparticles and, third, the higher aﬃnity of the
Fig. 2 (a) Scheme of the solid-phase synthesis of nanoMIPs. In this example, a protein is shown as the template molecule. (b) Representative TEM
of biotin MIPs.
Table 1 Hydrodynamic size of the four diﬀerent nanoMIPs by DLS in
distilled water
Target Size (nm) PDI
Biotin 161 ± 11 0.24
EGFR 239 ± 9 0.19
Vancomycin 275 ± 8 0.26
Trypsin 320 ± 7 0.22
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nanoMIPs towards its template. It is also an improvement
compared to the more conventional approach where MIP par-
ticles were functionalised onto an electrode surface rather
than directly on the thermocouple, which attained LoDs
between 25–100 nM for small molecules in buﬀered
solutions.23–25
Subsequently, thermocouples were coated with nanoMIPs
for, respectively, biotin, trypsin and vancomycin to determine
the wide applicability of this method. For all these, a similar
trend was observed and decreases in the temperature of the
thermocouple were monitored after addition of spiked PBS
solutions. The actual response in temperature for the three
nanoMIPs is provided in the ESI B–D.† The measured dose–
response curves are shown in Fig. 4-a. Measurements were per-
formed with both the actual target molecules and similar bio-
molecules, which provides insight into the selectivity of the
biosensor platform.
The four developed nanoMIPs all exhibit a reduction in the
measured thermocouple temperature (decrease ∼0.5 °C) after
exposure to solutions containing target molecules. With the
Fig. 3 (a) The temperatures T1 and T2 are represented in time, when the
signal is ﬁrst stabilised in PBS and after subsequent addition of solutions
with increasing concentrations of EGFR peptide (0–1000 nM). (b) Dose–
response curves are determined by dividing the diﬀerence in tempera-
ture at a certain concentration over the initial stabilization temperature.
Data (R2 = 0.99) is ﬁtted with an exponential function that reﬂects satur-
ation of the MIP binding sites.
Fig. 4 (A) The dose–response curve for the nanoMIPs towards its orig-
inal target biotin and to vitamin C. (B) Dose–response for trypsin
towards its original target and to pepsin. (C) Dose–response for
nanoMIPs designed for vancomycin and its response towards the orig-
inal target and to teicoplanin. All selectivity experiments were performed
with freshly prepared functionalised thermocouples. Data is ﬁtted with
an exponential function (R2 > 0.95 for all data) that reﬂects saturation of
the binding sites at higher concentrations.
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use of the dose–response curves (Fig. 4a–c), LoDs of ∼3–5 nM
were determined in buﬀered solutions. While LoDs were similar
for the four nanoMIPs, there were minor diﬀerences in the
maximum response of the thermal signal. For instance, for
EGFR nanoMIPs a response of 1.90% was measured while for
vancomycin 0.65% was attained. There could be several expla-
nations, including the higher aﬃnity of the EGFR nanoMIP,
smaller size of vancomycin that leads to lower attenuation of the
heat-transfer resistance, or diﬀerences in available surface area.
The selectivity of the thermal sensor was evaluated by com-
paring the signal of a given MIP over that of a similar molecule
at a certain concentration (selectivity factor, see Table 2). For
EGFR and biotin, selectivity factors (SF) of >4 were determined
at concentrations of 100 nM. These are slightly higher at lower
concentrations (∼5) compared to higher concentrations (∼3),
which is because at a certain point saturation of the binding
sites occurs. For vancomycin, the SF of 1.7 is lower compared
to MIPs designed for other template molecules. This might be
due to the fact that teicoplanin bears a very high structural
similarity to vancomycin. Ascorbic acid was chosen as speci-
ficity target for biotin because they are both vitamins and
therefore likely to compete with each other in the same sample
matrix. These results are assembled in Table 2.
LoDs that are obtained with this method are within the
therapeutic range of antibiotic compounds in serum.
Therefore, within a clinical setting, there is a demand to
monitor in vivo pharmacokinetics of these drugs. Vancomycin
is administered to treat severe infections and levels are moni-
tored to maintain its concentration above a threshold but
below levels that are associated with toxicity and side eﬀects.30
As proof-of-application for measurements in complex
samples, an experiment was performed with spiked saliva
samples. The electrodes were stabilized in PBS and after sub-
sequent addition of saliva, the temperature decreased by 10%
due to the matrix eﬀect of the saliva. Subsequently, spiked
saliva samples were administered each 30 min and these
results are shown in Fig. 5.
Saliva is viscous and this complicates administration of
samples by the automated syringe pump, which is why the
samples were diluted with PBS. However, samples were diluted
50/50, meaning it remained an accurate representation of a
complex matrix. While error bars are significantly higher due
to the presence of matrix compounds, such as proteins, there
are significant diﬀerences in thermal response observed to the
saliva samples spiked with EGFR (linear range 0–500 nM).
This is a clear indication that this methods hold promise for
the detection of complex samples, and we could improve the
noise on the significantly (from 0.15% in Fig. 5 to 0.05%) if we
would apply a gentle percentile filter to the data.
There is also a need to measure protein concentrations for
healthcare applications, and we present the first MIP-based
sensor for the thermal detection of these compounds. This
sensor platform could provide a viable alternative to existing
vitamin tests, since serum biotin levels of <200 ng L−1 are
associated with hair loss, dermatitis, or underlying metabolic
disorders.31 This emerging thermal technology has room for
improvement, for instance by adapting the temperature of the
baseline to increase eﬀect sizes. We have considered tempera-
tures of 37 °C since this mimics in vivo conditions and has a
significant diﬀerence with the ambient temperature in the lab,
which promotes heat-flow and enhances stability of the signal.
Measuring at lower temperatures could enhance the eﬀect size
which makes it of interest for biomarkers assays, but then the
stability of the current temperature control unit would then
need to be considered. Relevant biomarker assays include the
EGFR test, used to predict the recurrence of breast and lung
cancer.32 This method has the potential to be integrated in a
portable device and can be transferred into a traﬃc light
format, where patients would receive a warning if they will
need to consult a doctor for further testing.
Another approach that can be considered to improve detec-
tion limits includes the use of Thermal Wave Transport
Analysis.23 This method involves the analysis of modulated
sinusoidal temperature signals that are imposed onto a linear
temperature. It enhances overall stability of the signal and
temperature adjustments of only 0.1 °C are required. Using
TWTA could enhance specificity of the thermal sensors and is
particularly interesting for in vivo applications since only
minimal local heating (for instance a patch on a patient) is
needed.
Fig. 5 The thermal response and dose–response curve for nanoMIPs
designed for EGFR towards saliva samples (diluted 1 : 1 with PBS)
towards spiked EGFR samples (0–1000 nM). Error bars are determined
by averaging 100 data points at certain concentrations.
Table 2 Overview of the sensor characteristics for the four diﬀerent
nanoMIPs
Target
LoD
(nM)
Response at
1000 nM (%)
Selectivity factor
(c = 100 nM)
Linear
range
(nM)Target/competitor
EGFR 3 ± 1 1.9 ± 0.1 4.5 0–500
Biotin 5 ± 2 0.8 ± 0.05 4.3 0–100
Trypsin 5 ± 2 0.98 ± 0.05 2.3 0–500
Vancomycin 4 ± 1 0.65 ± 0.03 1.7 0–100
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4. Conclusions
MIP nanoparticles were synthesised against biotin, vancomy-
cin, an EGFR peptide and trypsin according to a solid-phase
synthetic approach. The solid support was used as a medium
to isolate the high aﬃnity nanoMIPs after polymerisation.
A homogeneous distribution of particles (in the range
161–320 nm) was obtained, which was confirmed by TEM ana-
lysis and measuring the hydrodynamic radius in water using
DLS. Subsequently, the nanoMIPs were dissolved into water
and dipcoated onto thermocouples of type K. The functiona-
lised thermocouples were inserted into a device that measures
the temperature of the liquid inside a flow cell developed
according to a home-made design. To establish the baseline,
the heat sink of the flow cell was kept at a constant tempera-
ture of 37.00 ± 0.02 °C. Significant drops in the temperature
(∼0.50 ± 0.02 °C) measured by the MIP functionalised thermo-
couples were reported after addition of buﬀered solutions with
template concentrations in the range of 5–500 nM. This decrease
in the temperature is due to the attachment of the template to
the MIP layer blocking the heat-transfer resistance at the inter-
face of the thermocouple, leading to an overall lower tempera-
ture in the liquid of the flow cell. Dose–response curves were
measured to determine the LoD of the sensors and correlate the
template concentration to the decrease in measured tempera-
ture. In addition, selectivity of the thermal sensors was evaluated
by exposing them to solutions of molecules that are similar in
size, shape and function to the template.
This demonstrates the general applicability of nanoMIPs as
recognition elements in thermal sensing. LoDs are obtained in
the low nanomolar range, which is an increase by three orders
of magnitude compared to previous works when bulk MIP
microparticles were attached onto thermocouples. This step
change can be explained by the use of nanoMIPs, which are pre-
selected to have high aﬃnity binding sites, and have a smaller
layer thickness that promotes heat-flow through the surface.
The use of thermal sensing in combination with MIP
technology can oﬀer sensors that are able to detect bio-
molecules in a straightforward, low-cost and fast (<5 min)
manner. The described methodology is versatile and can be
tailored to the requested target molecule by adjusting the
nanoMIP layer. In this contribution, we have presented the
first MIP-based sensor for thermal detection of proteins.
In light of the use of this biocompatible recognition layer,
this represents the first step towards an in vivo sensor platform
with great potential for a range of industries, as well as in bio-
medical and clinical research.
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